1. P01.012 Tumor Treating Fields (TTFields) in combination with lomustine (CCNU) and temozolomide (TMZ) in patients with newly diagnosed glioblastoma (GBM). (19th September 2018) Authors: Lazaridis, L; Schäfer, N; Kebir, S; Weller, J; Tzaridis, T; Scheffler, B; Pierscianek, D; Kleinschnitz, C; Stuschke, M; Sure, U; Herrlinger, U; Glas, M Journal: Neuro-oncology Issue: Volume 20(2018)Supplement 3 Page Start: iii230 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P01.060 PriCoTTF: a phase I/II trial of Tumor Treating Fields prior and concomitant to radiotherapy in newly diagnosed glioblastoma. (19th September 2018) Authors: Glas, M; Scheffler, B; Lazaridis, L; Herrlinger, U; Pierscianek, D; Sure, U; Pröscholdt, M; Hau, P; Hense, J; Kleinschnitz, C; Grosu, A; Stuschke, M; Kebir, S Journal: Neuro-oncology Issue: Volume 20(2018)Supplement 3 Page Start: iii243 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Association of aneurysms and variation of the A1 segment. (23rd April 2013) Authors: Krasny, A; Nensa, F; Sandalcioglu, I E; Göricke, S L; Wanke, I; Gramsch, C; Sirin, S; Oezkan, N; Sure, U; Schlamann, M Journal: Journal of neurointerventional surgery Issue: Volume 6:Number 3(2014) Page Start: 178 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. P17.04.B Combination of Trofosfamide and Etoposide in Recurrent Glioma. (5th September 2022) Authors: Schmidt, T; Agkatsev, S; Feldheim, J; Oster, C; Blau, T; Sure, U; Keyvani, K; Kleinschnitz, C; Stuschke, M; Hermann, K; Deuschl, C; Scheffler, B; Kebir, S; Glas, M; Lazaridis, L Journal: Neuro-oncology Issue: Volume 24(2022)Supplement 2 Page Start: ii89 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. P11.15.B First multicentric real-life experience with the combination of lomustine and temozolomide in newly diagnosedMGMT promoter methylatedIDH wildtype glioblastoma. (5th September 2022) Authors: Lazaridis, L; Schmidt, T; Agkatsev, S; Blau, T; Spille, D; Heider, S; Schulz, T; Bumes, E; Oster, C; Feldheim, J; Stummer, W; Kessler, A; Seidel, C; Hau, P; Sure, U; Keyvani, K; Herrlinger, U; Kleinschnitz, C; Stuschke, M; Herrmann, K Journal: Neuro-oncology Issue: Volume 24(2022)Supplement 2 Page Start: ii58 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. P14.64 PriCoTTF Trial: A phase I/II trial of TTFields prior and concomitant to radiotherapy in newly diagnosed glioblastoma. (9th September 2021) Authors: Kebir, S; Pierscianek, D; Proescholdt, M; Hau, P; Grosu, A; Krex, D; Sure, U; Scheffler, B; Stuschke, M; Glas, M Journal: Neuro-oncology Issue: Volume 23: Supplement 2 (2021) Page Start: ii50 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Silent embolism after stent-assisted coiling of cerebral aneurysms: diffusion-weighted MRI study of 75 cases. (8th August 2013) Authors: Hahnemann, M L; Ringelstein, A; Sandalcioglu, I E; Goericke, S; Moenninghoff, C; Wanke, I; Forsting, M; Sure, U; Schlamann, M Journal: Journal of neurointerventional surgery Issue: Volume 6:Number 6(2014) Page Start: 461 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. P120 International similarities and differences in hereditary haemorrhagic telangiectasia (HHT) pathways reported by patients and clinicians. (12th November 2019) Authors: Boother, EJ; von Widekind, SJ; Post, M; Kjeldsen, AD; Mager, HJ; Pagella, F; Sabba, C; Sure, U; Buscarini, E; Dupuis-Girod, S; Shovlin, CL Journal: Thorax Issue: Volume 74(2019)Supplement 2 Page Start: A156 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. P14.61 Tumor Treating Fields (TTFields) combined with lomustine (CCNU) and temozolomide (TMZ) in newly diagnosed glioblastoma (GBM) patients - a bi-centric analysis. (6th September 2019) Authors: Lazaridis, L; Schäfer, N; Schmidt, T; Stoppek, A; Weller, J; Tzaridis, T; Scheffler, B; Pierscianek, D; Kleinschnitz, C; Stuschke, M; Sure, U; Herrlinger, U; Kebir, S; Glas, M Journal: Neuro-oncology Issue: Volume 21(2019)Supplement 3 Page Start: iii81 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗